Endoscopy 2012; 44(12): 1158-1160
DOI: 10.1055/s-0032-1325795
Case report
© Georg Thieme Verlag KG Stuttgart · New York

Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantation

Authors

  • I. Kabar

    1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
  • V. R. Cicinnati

    1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
  • S. Beckebaum

    1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
  • S. Cordesmeyer

    1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
  • Y. Avsar

    1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
  • H. Reinecke

    2   Division of Angiology, Department of Cardiology and Angiology, University Hospital Münster, Münster, Germany
  • H. H. Schmidt

    1   Department of Transplant Medicine, University Hospital Münster, Münster, Germany
Further Information

Publication History

Publication Date:
27 November 2012 (online)

Biliary anastomotic strictures after liver transplantation are a major source of morbidity and graft failure; however, repeated endoscopic therapy has shown variable long-term success rates. Thus the aim of this prospective case series was to evaluate the safety and efficacy of using paclitaxel-eluting balloons in 13 patients requiring treatment for symptomatic anastomotic strictures following liver transplantation. Sustained clinical success—defined as no need for further endoscopic intervention for at least 6 months – was achieved in 12 /13 patients (92 %). One, two, and three interventions were required in 9 (69 %), 1, and 2 patients, respectively (mean number of sessions was 1.46). Mean (± SD) bilirubin level dropped from 6.8 (± 4.1) mg/dL to 1.4 (± 0.9) mg/dL. These promising results justify carrying out a randomized comparative trial to confirm this innovative approach.